AUTHOR=Chai Lirong , Zhang Kai , Zhang Yi , Wang Weijing , Zhang Dongfeng , Fan Junning 

TITLE=Associations between Life’s Essential Eight cardiovascular health metrics and cardiovascular mortality risk across frailty statuses: evidence from a UK Biobank cohort study

JOURNAL=Frontiers in Public Health

VOLUME=Volume 13 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1508274

DOI=10.3389/fpubh.2025.1508274

ISSN=2296-2565

ABSTRACT=BackgroundHigher cardiovascular health (CVH) scores are related to lower risk of cardiovascular disease (CVD) mortality, and frailty status may moderate the association. Whether the associations of Life’s Essential 8 (LE8) with mortality from CVD and its subtypes differ across frailty status remains unknown. Therefore, we aimed to assess the association between LE8 and CVD mortality among individuals with different frailty status.MethodsData were sourced from the UK Biobank of 439,462 participants aged 37–73 years. LE8, as a metric of CVH, was assessed using four health behaviors (diet, physical activity, nicotine exposure, and sleep health) and four health factors (body mass index, blood lipids, blood glucose, and blood pressure). Frailty status was measured with frailty index (FI) and Fried phenotype (FP). The outcomes included mortality of CVD, coronary heart disease, and cerebrovascular disease. Cox regression was used to calculate hazard ratios (HR) and 95% confidence intervals (CI) to assess the association, and additive and multiplicative interactive effects were also examined.ResultsOver a median follow-up period of 13.7 [interquartile range 13.0–14.4] years, 6,085 participants died from CVD. The moderate or high level of LE8 lowered the risk of CVD mortality with HRs (95% CIs) of (0.50, 0.47–0.53) and (0.25, 0.22–0.29), respectively. The effect did not differ in individuals with different frailty status (Pinteraction > 0.05), each group with an HR of about 0.3. Compared with those with low LE8 and frail, the HR for individuals who are not frail and with high LE8 level was about 0.15. Similar results were found for endpoints of CVD subtypes and for participants of all ages and sexes, and specifically, CVH appeared to be better protected for CVD mortality in those who were not treated for blood pressure, cholesterol, and diabetes.ConclusionIdeal CVH was associated with lower risk of CVD mortality regardless of frailty status. Specifically, for frail participants, optimizing CVH is a cost-effective strategy to mitigate CVD risk and promote healthy ageing.